Cargando…
Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution
Introduction The gold standard treatment of stage I non-small cell lung cancer (NSCLC) is surgical resection. For medically inoperable patients, stereotactic body radiation therapy (SBRT) can provide comparable local control (LC) and overall survival (OS). The objectives of this study are to determi...
Autores principales: | Doupnik, Nathan P, Hirmiz, Khalid, Hussein, Abdulkadir A, Agapito, John, Pan, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901134/ https://www.ncbi.nlm.nih.gov/pubmed/35273848 http://dx.doi.org/10.7759/cureus.21878 |
Ejemplares similares
-
Clinical Outcomes After Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer: A Single Institutional Study
por: Abdalmassih, Michael, et al.
Publicado: (2020) -
Reduced Margin Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancers
por: Patel, Mayank, et al.
Publicado: (2020) -
Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma
por: Jumeau, Raphaël, et al.
Publicado: (2016) -
Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy (SBRT) Outcomes in an Equal Access Military Setting
por: Chaurasia, Avinash R, et al.
Publicado: (2021) -
Single Institution Experience of Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer: Comparison of Two Dose Regimes and a Perspective on Ideal Dose Regimens
por: Nittala, Mary R, et al.
Publicado: (2021)